Provided by Tiger Trade Technology Pte. Ltd.

Novavax

8.54
+0.12001.43%
Pre-market: 8.550.0100+0.12%05:14 EDT
Volume:2.31M
Turnover:19.60M
Market Cap:1.39B
PE:3.31
High:8.60
Open:8.41
Low:8.32
Close:8.42
52wk High:11.97
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:0.71
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.58
EPS(LYR):2.58
ROE:-898.20%
ROA:25.72%
PB:-10.86
PE(LYR):3.31

Loading ...

Stock Track | Novavax Soars 11.52% Intraday on Bullish Option Flow

Stock Track
·
Jan 22

Novavax call volume above normal and directionally bullish

TIPRANKS
·
Jan 21

Novavax: Execution Risks, Long-Dated Cash Flows, and COVID Market Headwinds Undermine Profitability Outlook

TIPRANKS
·
Jan 21

Novavax: Pfizer Partnership Validates Matrix‑M Platform and Supports Upside in Capital‑Light Growth Strategy

TIPRANKS
·
Jan 21

Novavax Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 21

Novavax Price Target Maintained With a $19.00/Share by BTIG

Dow Jones
·
Jan 21

Novavax price target raised to $7 from $6 at BofA

TIPRANKS
·
Jan 20

Novavax: Expanding Matrix-M Licensing Partnerships Drive Upside Potential and Support Buy Rating

TIPRANKS
·
Jan 20

Novavax Shares Gain 3% Premarket After Signing Licensing Agreement With Pfizer for Vaccine Development

THOMSON REUTERS
·
Jan 20

Novavax Announces Entering Into a License Agreement With Pfizer

THOMSON REUTERS
·
Jan 20

Stock Track | Novavax Soars 7.12% in Pre-market on License Agreement With Pfizer

Stock Track
·
Jan 20

Novavax Signs License Agreement With Pfizer for Matrix-M Adjuvant Technology

Reuters
·
Jan 20

Novavax Inc - Enters License Agreement With Pfizer - SEC Filing

THOMSON REUTERS
·
Jan 20

Novavax: Pfizer to Have Control of Matters Relating to Development, Manufacture & Commercialization of Products That Contain Adjuvant

THOMSON REUTERS
·
Jan 20

Novavax Inc - Eligible for up to $500 Mln in Milestone Payments - SEC Filing

THOMSON REUTERS
·
Jan 20

Novavax Inc - to Receive $30 Mln Upfront Payment in Q1 2026 - SEC Filing

THOMSON REUTERS
·
Jan 20

Novavax Inc. Stock Falls 5.0%, Underperforms Peers

Dow Jones
·
Jan 16

CORRECTED: Why Is Novavax Stock Soaring?

Benzinga_recent_news
·
Jan 14

Novavax Inc. Stock Rises 6.6%, Outperforms Peers

Dow Jones
·
Jan 13

A Look At Novavax (NVAX) Valuation After Singapore JN.1 Vaccine Rollout And Revenue Beat

Simply Wall St.
·
Jan 05